(Gal)3 (GalNAc)1 (Glc)1 (GlcNAc)2 (LFuc)1 (Cer)1
|
KEGG GLYCAN
|
a neolactoside VI3- α- GalNAc,VI2- α- Fuc- nLc6Cer(d18:1(4E))
|
UniProt
|
α- D- GalNAc- (1→3)- [α- L- Fuc- (1→2)]- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- β- D- Gal- (1→4)- β- D- Glc- Cer
|
ChEBI
|
α- D- GalpNAc- (1→3)- [α- L- Fucp- (1→2)]- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1→1')- Cer
|
ChEBI
|
α- D- GalpNAc- (1→3)- [α- L- Fucp- (1→2)]- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- Cer
|
ChEBI
|
blood group antigen Ab
|
ChEBI
|
GalNAcα1→3(Fucα1→2)Gal1→4βGlcNAcβ1→3Galβ1→4GlcNAcβ1→3Galβ1→4Glcβ1→Cer
|
ChEBI
|
N- [(2S,3R,4E)- 1- {[2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→3)- [6- deoxy- α- L- galactopyranosyl- (1→2)]- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→3)- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→3)- β- D- galactopyranosyl- (1→4)- β- D- glucopyranosyl]oxy}- 3- hydroxyoctadec- 4- en- 2- yl]alkanamide
|
IUPAC
|
N- acetyl- α- D- galactosaminyl- (1→3)- [α- L- fucosyl- (1→2)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1→1')- ceramide
|
ChEBI
|
N- acetyl- α- D- galactosaminyl- (1→3)- [α- L- fucosyl- (1→2)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
|
ChEBI
|